Puma Biotechnology Aktie
2,77
EUR
-0,02
EUR
-0,72
%
2,94
USD
+0,06
USD
+1,91
%
Werbung
Puma Biotechnology Aktie Analyse
10.05.19 | Puma Biotechnology Neutral | Cantor Fitzgerald | |
01.10.18 | Puma Biotechnology Overweight | Cantor Fitzgerald | |
11.05.18 | Puma Biotechnology Buy | Stifel, Nicolaus & Co., Inc. | |
10.11.17 | Puma Biotechnology Sector Perform | RBC Capital Markets | |
02.10.17 | Puma Biotechnology Buy | Stifel, Nicolaus & Co., Inc. | |
06.06.17 | Puma Biotechnology Sector Perform | RBC Capital Markets | |
25.05.17 | Puma Biotechnology Sector Perform | RBC Capital Markets | |
02.03.17 | Puma Biotechnology Sector Perform | RBC Capital Markets | |
Werbung
|
|||
21.09.16 | Puma Biotechnology Buy | Stifel, Nicolaus & Co., Inc. | |
29.03.16 | Puma Biotechnology Sector Perform | RBC Capital Markets | |
23.01.15 | Puma Biotechnology Outperform | RBC Capital Markets |
Werbung
Werbung